| Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination L Hammerich, TU Marron, R Upadhyay, J Svensson-Arvelund, ... Nature medicine 25 (5), 814-824, 2019 | 343 | 2019 |
| Role of IL-17 and Th17 cells in liver diseases L Hammerich, F Heymann, F Tacke Journal of Immunology Research 2011, 2011 | 326 | 2011 |
| Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis A Wehr, C Baeck, F Heymann, PM Niemietz, L Hammerich, C Martin, ... The Journal of Immunology 190 (10), 5226-5236, 2013 | 274 | 2013 |
| Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury F Heymann, C Meyer-Schwesinger, EE Hamilton-Williams, L Hammerich, ... The Journal of clinical investigation 119 (5), 1286-1297, 2009 | 248 | 2009 |
| Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis L Hammerich, JM Bangen, O Govaere, HW Zimmermann, N Gassler, ... Hepatology 59 (2), 630-642, 2014 | 193 | 2014 |
| Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice F Heymann, L Hammerich, D Storch, M Bartneck, S Huss, V Rüsseler, ... Hepatology 55 (3), 898-909, 2012 | 186 | 2012 |
| In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf L Hammerich, A Binder, JD Brody Molecular oncology 9 (10), 1966-1981, 2015 | 184 | 2015 |
| Origin of regenerating tubular cells after acute kidney injury K Berger, JM Bangen, L Hammerich, C Liedtke, J Floege, B Smeets, ... Proceedings of the National Academy of Sciences 111 (4), 1533-1538, 2014 | 172 | 2014 |
| Interleukins in chronic liver disease: lessons learned from experimental mouse models L Hammerich, F Tacke Clinical and experimental gastroenterology, 297-306, 2014 | 160 | 2014 |
| RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8-and JNK-dependent compensatory cell proliferation M Vucur, F Reisinger, J Gautheron, J Janssen, C Roderburg, ... Cell reports 4 (4), 776-790, 2013 | 143 | 2013 |
| Kidney dendritic cells become pathogenic during crescentic glomerulonephritis with proteinuria K Hochheiser, DR Engel, L Hammerich, F Heymann, PA Knolle, U Panzer, ... Journal of the American Society of Nephrology 22 (2), 306-316, 2011 | 97 | 2011 |
| In situ vaccination for the treatment of cancer L Hammerich, N Bhardwaj, HE Kohrt, JD Brody Immunotherapy 8 (3), 315-330, 2016 | 91 | 2016 |
| Role of gamma-delta T cells in liver inflammation and fibrosis L Hammerich, F Tacke World journal of gastrointestinal pathophysiology 5 (2), 107, 2014 | 84 | 2014 |
| Dendritic cell and T cell crosstalk in liver fibrogenesis and hepatocarcinogenesis: implications for prevention and therapy of liver cancer I Lurje, L Hammerich, F Tacke International journal of molecular sciences 21 (19), 7378, 2020 | 76 | 2020 |
| Hepatic inflammatory responses in liver fibrosis L Hammerich, F Tacke Nature Reviews Gastroenterology & Hepatology 20 (10), 633-646, 2023 | 72 | 2023 |
| Lymphoma: immune evasion strategies R Upadhyay, L Hammerich, P Peng, B Brown, M Merad, JD Brody Cancers 7 (2), 736-762, 2015 | 53 | 2015 |
| Targeting CCl4‐induced liver fibrosis by RNA interference–mediated inhibition of cyclin E1 in mice JM Bangen, L Hammerich, R Sonntag, M Baues, U Haas, D Lambertz, ... Hepatology 66 (4), 1242-1257, 2017 | 50 | 2017 |
| Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis L Hammerich, F Tacke World journal of gastrointestinal pathophysiology 6 (3), 43, 2015 | 50 | 2015 |
| In situ vaccination as a strategy to modulate the immune microenvironment of hepatocellular carcinoma I Lurje, W Werner, R Mohr, C Roderburg, F Tacke, L Hammerich Frontiers in Immunology 12, 650486, 2021 | 38 | 2021 |
| Cyclic adenosine monophosphate–responsive element modulator alpha overexpression impairs function of hepatic myeloid‐derived suppressor cells and aggravates immune‐mediated … L Hammerich, KT Warzecha, M Stefkova, M Bartneck, K Ohl, N Gassler, ... Hepatology 61 (3), 990-1002, 2015 | 36 | 2015 |
